Literature DB >> 24662436

Imaging: BOLD assessment--effects of RAAS inhibition in CKD.

Lilach O Lerman1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24662436     DOI： 10.1038/nrneph.2014.58

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

1.  Noninvasive evaluation of kidney hypoxia and fibrosis using magnetic resonance imaging.

Authors:  Tsutomu Inoue; Eito Kozawa; Hirokazu Okada; Kouichi Inukai; Shinichi Watanabe; Tomohiro Kikuta; Yusuke Watanabe; Tsuneo Takenaka; Shigehiro Katayama; Junji Tanaka; Hiromichi Suzuki
Journal:  J Am Soc Nephrol       Date:  2011-07-14       Impact factor: 10.121

2.  Roles of oxidative stress and AT1 receptors in renal hemodynamics and oxygenation in the postclipped 2K,1C kidney.

Authors:  William J Welch; Margarida Mendonca; Shakil Aslam; Christopher S Wilcox
Journal:  Hypertension       Date:  2003-01-20       Impact factor: 10.190

3.  Angiotensin II receptor blocker partially ameliorated intrarenal hypoxia in chronic kidney disease patients: a pre-/post-study.

Authors:  K Manotham; B Ongvilawan; P Urusopone; S Chetsurakarn; J Tanamai; P Limkuansuwan; K Tungsanga; S Eiam-Ong
Journal:  Intern Med J       Date:  2012-04       Impact factor: 2.048

4.  Blood oxygen level-dependent magnetic resonance imaging identifies cortical hypoxia in severe renovascular disease.

Authors:  Monika L Gloviczki; James F Glockner; John A Crane; Michael A McKusick; Sanjay Misra; Joseph P Grande; Lilach O Lerman; Stephen C Textor
Journal:  Hypertension       Date:  2011-10-31       Impact factor: 10.190

5.  Comparison of 1.5 and 3 T BOLD MR to study oxygenation of kidney cortex and medulla in human renovascular disease.

Authors:  Monika L Gloviczki; James Glockner; Sabas I Gomez; Juan C Romero; Lilach O Lerman; Michael McKusick; Stephen C Textor
Journal:  Invest Radiol       Date:  2009-09       Impact factor: 6.016

6.  Renal BOLD-MRI does not reflect renal function in chronic kidney disease.

Authors:  Henrik J Michaely; Linda Metzger; Stefan Haneder; Jan Hansmann; Stefan O Schoenberg; Ulrike I Attenberger
Journal:  Kidney Int       Date:  2012-01-11       Impact factor: 10.612

7.  Blockade of the renin-angiotensin system and renal tissue oxygenation as measured with BOLD-MRI in patients with type 2 diabetes.

Authors:  Menno Pruijm; Lucie Hofmann; Anne Zanchi; Marc Maillard; Valentina Forni; Marie-Eve Muller; Grégoire Wuerzner; Bruno Vogt; Matthias Stuber; Michel Burnier
Journal:  Diabetes Res Clin Pract       Date:  2012-12-14       Impact factor: 5.602

8.  The use of magnetic resonance to evaluate tissue oxygenation in renal artery stenosis.

Authors:  Stephen C Textor; James F Glockner; Lilach O Lerman; Sanjay Misra; Michael A McKusick; Stephen J Riederer; Joseph P Grande; S Ivan Gomez; J Carlos Romero
Journal:  J Am Soc Nephrol       Date:  2008-02-20       Impact factor: 10.121

9.  Blood pressure, blood flow, and oxygenation in the clipped kidney of chronic 2-kidney, 1-clip rats: effects of tempol and Angiotensin blockade.

Authors:  Fredrik Palm; Maristela Onozato; William J Welch; Christopher S Wilcox
Journal:  Hypertension       Date:  2010-01-04       Impact factor: 10.190

10.  Inhibition of the renin-angiotensin system affects kidney tissue oxygenation evaluated by magnetic resonance imaging in patients with chronic kidney disease.

Authors:  Laima Siddiqi; Hans Hoogduin; Freddy Visser; Tim Leiner; Willem P Mali; Peter J Blankestijn
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-02-20       Impact factor: 3.738
  10 in total
  2 in total

Review 1.  Atherosclerotic renal artery stenosis: current status.

Authors:  Soon Hyo Kwon; Lilach O Lerman
Journal:  Adv Chronic Kidney Dis       Date:  2015-05       Impact factor: 3.620

2.  Autophagosome protects proximal tubular cells from aldosterone-induced senescence through improving oxidative stress.

Authors:  Jing-Yuan Cao; Li-Lu Ling; Wei-Jie Ni; Hong-Lei Guo; Min Yang
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.